1. Home
  2. ACTG vs MGTX Comparison

ACTG vs MGTX Comparison

Compare ACTG & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acacia Research Corporation (Acacia Tech)

ACTG

Acacia Research Corporation (Acacia Tech)

HOLD

Current Price

$4.27

Market Cap

440.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$10.90

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACTG
MGTX
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
440.1M
1.1B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
ACTG
MGTX
Price
$4.27
$10.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$6.00
★ $24.57
AVG Volume (30 Days)
167.8K
★ 824.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 161.11
33.02
EPS
N/A
★ 1.30
Revenue
$12,004,000.00
★ $81,391,000.00
Revenue This Year
N/A
$141.38
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$8.50
Revenue Growth
N/A
★ 144.57
52 Week Low
$3.15
$6.62
52 Week High
$5.27
$15.35

Technical Indicators

Market Signals
Indicator
ACTG
MGTX
Relative Strength Index (RSI) 31.22 26.47
Support Level $3.86 $8.84
Resistance Level $4.30 $11.85
Average True Range (ATR) 0.11 0.56
MACD -0.03 -0.28
Stochastic Oscillator 13.16 9.42

Price Performance

Historical Comparison
ACTG
MGTX

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations, and Manufacturing Operations. It derives revenue from the Intellectual Property Operations segment. Geographically, it operates in the Americas, Europe, the Middle East and Africa, China, India, and Asia-Pacific.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: